A randomized controlled trial of imipramine in patients with irritable bowel syndrome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

587

HTML

3442

Figures (1-3)

194

Tables (1-3)

203

Sum=4426

Aug 7, 2009 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Aug 7, 2009; 15(29): 3636-3642
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3636

Full Size Figure Download Figure

Figure 2 Rate of global symptom relief (A) per-protocol and (B) per intent-to-treat analysis (^aP < 0. 05).

Citation: Abdul-Baki H, El Hajj II, ElZahabi L, Azar C, Aoun E, Skoury A, Chaar H, Sharara AI. A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol 2009; 15(29): 3636-3642
URL: https://www.wjgnet.com/1007-9327/full/v15/i29/3636.htm
DOI: https://dx.doi.org/10.3748/wjg.15.3636